Novavax Inc (NASDAQ:NVAX)

During the Trading Day
9.31 -0.02 / -0.21%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.79 -0.52 / -5.59%
 
Volume: 105.5K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.2B

Company Description

Novavax, Inc. is a clinical-stage biopharmaceutical company, which engages in development of novel recombinant vaccines to address a broad range of infectious diseases. The company's technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles and recombinant nanoparticle vaccines. Its product pipeline targets a variety of infectious diseases and currently has completed clinical trials that target pandemic influenza (H5N1), seasonal influenza and Respiratory Syncytial Virus. Novavax was founded in 1987 and is headquartered in Gaithersburg, MD.

Contact Information

Novavax, Inc.
9920 Belward Campus Drive
Rockville Maryland 20850
P:(240) 268-2000
Investor Relations:

Employees

Shareholders

Mutual fund holders45.77%
Other institutional17.38%
Individual stakeholders10.30%

Top Executives

There are no executives to display.

To view my watchlist

Not a member yet?

Sign up now for a free account